[New therapeutic approachs in melanoma].
During the last decade, new insights in cellular and molecular biology have opened new avenues in cancer immunotherapy. Two distinct modalities have been developed: adoptive immunotherapy and anti-tumoral vaccination (active immunotherapy). We will first describe the main strategies of adoptive immunotherapy and then elaborate on the protocols of anti-tumoral vaccination against tumor associated antigens (TAA). In that context, we will pay peculiar attention on the pivotal role of dendritic cells (DC) as natural adjuvant.
Services d'Oncologie médicale, Hôpital Erasme, ULB.
L
L
Mortier
P
P
Marchetti
L
L
Gordower
A S
AS
Charbonnier-Hatzfeld
M
M
Toungouz
T
T
Velu
D019496:Cancer Vaccines / Q000627:therapeutic use*; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008545:Melanoma / Q000235:genetics / Q000276:immunology* / Q000628:therapy*
D019496:Cancer Vaccines